3 ·Filed Aug 6, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
Monitor future Form 4 filings for any open-market purchases or sales by the CFO, which would provide a clearer signal on insider conviction. This filing alone does not warrant trading action.
Latest settled — T+20d ⚠ clustered
BLSM ▲ +37.56% at T+20d
NEUTRAL call +37.56% · α vs SPY +37.96% · entry $16.00 → $22.01
T+1d
-0.06%
call -0.06% · α -0.03%
$15.99
settled 3mo ago
T+5d
+1.13%
call +1.13% · α +0.73%
$16.18
settled 3mo ago
T+20d
+37.56%
call +37.56% · α +37.96%
$22.01
settled 8w ago
T+60d
Pending
in 2d
Price Chart
Loading chart...
Executive Summary
CFO Jason Keyes filed a Form 3 initial statement of beneficial ownership, disclosing 175,417 employee stock options exercisable at $6.28 per share. This is a routine filing for a newly appointed officer and carries no material financial or operational information.
Key Facts
- Jason Keyes appointed as CFO of BlossomHill Therapeutics
- Disclosed 175,417 employee stock options with $6.28 strike price, expiring May 5, 2035
- Options are immediately exercisable
- No other securities beneficially owned reported
Financial Impact
No financial impact; routine insider ownership disclosure
Risk Factors
- No material risks identified from this filing
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001678152-26-000002 |
| Document: 0001678152-26-000002-index-headers.html | 0001678152-26-000002 |
| Document: 0001678152-26-000002-index.html | 0001678152-26-000002 |
| Document: 0001678152-26-000002.txt | 0001678152-26-000002 |
16 reports for BLSM
100% Hit rate @ T+20 Went positive at some point 6 of 6 best @ T+20▲ +45.84%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 29d ago | Press Release | $21.34 $16.39 | ▲ +23.20% | ▲ +23.16% | $15.76 (+26.15%) |
Sep 18, 2026 5w ago | 8-K | $25.74 $13.94 | ▲ +45.84% | ▲ +46.05% | $15.76 (+38.77%) |
Sep 18, 2026 5w ago | Press Release | $25.74 $13.94 | ▼ −45.84% | ▼ −46.05% | $15.76 (−38.77%) |
Sep 15, 2026 6w ago | 8-K | $22.17 $15.48 | ▼ −30.18% | ▼ −33.15% | $15.76 (−28.91%) |
Aug 12, 2026 10w ago | Insider Cluster | $16.35 $20.86 | ▲ +27.58% | ▲ +29.33% | $15.76 (−3.61%) |
Aug 10, 2026 11w ago | Insider Cluster | $16.52 $22.00 | ▲ +33.17% | ▲ +34.23% | $15.76 (−4.60%) |
Aug 10, 2026 11w ago | 8-K | $16.52 $22.00 | ▲ +33.17% | ▲ +34.23% | $15.76 (−4.60%) |
Aug 7, 2026 11w ago | 424B4 | $15.99 $22.93 | ▲ +43.40% | ▲ +44.32% | $15.76 (−1.44%) |
Aug 7, 2026 11w ago | EFFECT | $16.00 $22.01 | ▲ +37.56% | ▲ +37.96% | $15.76 (−1.50%) |
Aug 6, 2026 11w ago | 3 | $16.00 $22.01 | ▲ +37.56% | ▲ +37.96% | $15.76 (−1.50%) |
Showing 10 of 16
US Market Status
Market Closed — Opens in 9h 25m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers